This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Keytruda
  • /
  • Study of Two Doses of MK-3475 (Pembrolizumab) Vers...
Clinical trial

Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

Read time: 1 mins
Last updated:1st Aug 2013
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest